A small phase 2a trial of GH001, an investigational psychedelic compound, found a rapid reduction in postpartum depression symptoms. Larger studies are needed to assess safety and durability.
Read the Latest News
Drawing on current research and clinical expertise, these articles address emerging trends, treatment considerations, and the complexities of care across the reproductive lifespan.
Melatonin is widely used as a sleep aid, but what do we know about its safety during pregnancy? Explore the evidence, potential risks, and treatment options.
Perinatal OCD is common but often missed by depression-only screens. Adding perinatal-specific anxiety and OCD tools can improve detection and guide targeted treatment.
Please join us in welcoming our NP Masterclass Fall 2026 cohort!
Sign up for our newsletter
Get the latest news in women’s mental health and our research.
"*" indicates required fields
